These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25514770)

  • 1. [Not Available].
    Aktuelle Urol; 2014 Nov; 45(6):430-1. PubMed ID: 25514770
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Men with breast cancer have increased risk of other cancers].
    Lorphelin H; Mortemousque I; Marret H; Body G; Ouldamer L
    Presse Med; 2014 Apr; 43(4 Pt 1):e33-8. PubMed ID: 24612706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular pathology of multifocal prostate cancer and its clinical application].
    Cheng L; Teng XD; Zhou J
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):436-9. PubMed ID: 22088367
    [No Abstract]   [Full Text] [Related]  

  • 5. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Campaign Program for Prostate Integrated Research].
    Cussenot O
    Bull Cancer; 2010 Dec; 97(12):1497-8. PubMed ID: 21284142
    [No Abstract]   [Full Text] [Related]  

  • 7. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colorectal cancer].
    Pox CP; Schmiegel W
    Dtsch Med Wochenschr; 2014 Jan; 139(5):193-202; quiz 203-6. PubMed ID: 24449354
    [No Abstract]   [Full Text] [Related]  

  • 9. Special report: recent developments in prostate cancer genetics and genetic testing.
    Technol Eval Cent Assess Program Exec Summ; 2009 Jan; 23(7):1-3. PubMed ID: 19297804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple carcinomas as sign of carcinoma disease].
    Bauer E
    Monatsschr Ohrenheilkd Laryngorhinol; 1966 Nov; 100(11):507-10. PubMed ID: 16114376
    [No Abstract]   [Full Text] [Related]  

  • 11. Report from Durham.
    Moul JW
    Prostate Cancer Prostatic Dis; 2008; 11(3):211. PubMed ID: 18711369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Projects of the 6th European Framework Program].
    Thalmann G
    Urologe A; 2007 Sep; 46(9):1274-8. PubMed ID: 17665161
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer: Multifocal disease--independent clonal lineages in malignant nodules and even in normal tissue.
    Thoma C
    Nat Rev Urol; 2015 Apr; 12(4):177. PubMed ID: 25782174
    [No Abstract]   [Full Text] [Related]  

  • 14. Personalising the treatment of prostate cancer.
    Gunjur A
    Lancet Oncol; 2015 Dec; 16(16):e592. PubMed ID: 26549591
    [No Abstract]   [Full Text] [Related]  

  • 15. Multifocal prostate cancer: biologic, prognostic, and therapeutic implications.
    Andreoiu M; Cheng L
    Hum Pathol; 2010 Jun; 41(6):781-93. PubMed ID: 20466122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial papillary (nonmedullary) thyroid carcinoma].
    Gärtner R
    Dtsch Med Wochenschr; 2012 Jul; 137(28-29):1474. PubMed ID: 22760408
    [No Abstract]   [Full Text] [Related]  

  • 17. [Not Available].
    Meissnitzer MW; Kubin K; Meissnitzer T
    Rofo; 2016 Oct; 188(10):965-6. PubMed ID: 27272687
    [No Abstract]   [Full Text] [Related]  

  • 18. Epigenetic test could eliminate repeat biopsies for prostate cancer.
    Printz C
    Cancer; 2014 Nov; 120(22):3428-9. PubMed ID: 25368970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cancer control in focus insights and future perspectives for the focal treatment of prostate cancer].
    Schostak M; Köllermann J; Hadaschik B; Blana A; Ganzer R; Henkel T; Köhrmann KU; Liehr UB; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D
    Aktuelle Urol; 2015 Jan; 46(1):39-44. PubMed ID: 25658230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guidelines for prostate cancer.
    Ahlering T; Parker R; Kumar S; Taylor C; Gilden R; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S77-86. PubMed ID: 9166527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.